Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies

Clinical trial NCT01564277 · TERMINATED

Trial details

NCT number: NCT01564277
Sponsor: Roswell Park Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Blastic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma de Novo Myelodysplastic Syndromes Noncontiguous Stage II Adult Burkitt Lymphoma Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia

Start date: 2011-09-29
Primary completion: 2015-05-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.